An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Magenta Therapeutics to Participate in Panel Discussion at the 42nd Annual Cowen Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Magenta Therapeutics (Nasdaq: MGTA) has announced its participation in a Cell Therapy Panel Discussion at the 42nd Annual Cowen Healthcare Conference, scheduled for March 9, 2022 at 9:10 a.m. ET. The event will be held virtually, and a live webcast will be available on the company's website, with a replay accessible for 30 days post-event. Magenta focuses on developing stem cell transplant medicines aimed at treating blood cancers, genetic and autoimmune diseases, leveraging its expertise in stem cell biology and biotherapeutics.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in a Cell Therapy Panel Discussion at the 42nd Annual Cowen Healthcare Conference, to be held virtually, on Wednesday, March 9th, 2022 at 9:10 a.m. ET.
About Magenta Therapeutics Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
Magenta is based in Cambridge, Massachusetts. For more information, please visit www.magentatx.com.
When is the Magenta Therapeutics panel discussion at the Cowen Healthcare Conference?
The panel discussion is scheduled for March 9, 2022, at 9:10 a.m. ET.
How can I watch the Magenta Therapeutics panel discussion?
A live webcast of the discussion can be accessed on the Magenta Therapeutics website.
What is the focus of Magenta Therapeutics?
Magenta Therapeutics develops medicines designed to enhance the curative power of stem cell transplants for blood cancers, genetic, and autoimmune diseases.
Where is Magenta Therapeutics based?
Magenta Therapeutics is based in Cambridge, Massachusetts.
What can I expect from the Cowen Healthcare Conference panel discussion featuring MGTA?
The panel will focus on advancements in cell therapy and its application in treating various diseases.
